HIF1A and breast carcinoma: In breast cancer, SENP1 inhibition prevents the deSUMOylation of hypoxia-inducible factor 1α (HIF-1α), ultimately leading to HIF-1α degradation and cancer metastasis suppression (Jia et al., 2020).